It is illustrative to put the individual components of the global diabetes market into context. Below is illustrated the global diabetes market segmented by geography, with further detail shown for the U.S. markets product segments. The U.S. represents the single largest share of the global diabetes market, with insulin, glucose meter test strips (not including [...]
The European market for ablation technologies shows considerable variation by modality and country, given the differences in adoption rates for the different modalities, the local practice patterns and other regional variations. Below is illustrated the distribution of the ablation market by modality across the major markets in Western Europe. Source: MedMarket DIligence, LLC; Report #A145, [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
(See PRLog press release at link.) As well established as the practices are for the management of types 1 and 2 diabetes, a raft of new technologies, from modest to radical, are steadily entering clinical practice and the industry, according to a new report from MedMarket Diligence. FOR IMMEDIATE RELEASE PRLog (Press Release) – Aug [...]
The global market for ablation technologies is characterized, like many medtech markets, by a dominance of revenues in western economies. There are nonetheless distinct patterns in the share of ablation by modality from one geography to the next. Below is a simple representation of the global ablation market by major region and modality (aggregated from [...]
Tissue engineering and cell therapy comprise a market for regenerative products that is expected to grow worldwide from $6.9 billion in 2009 to almost $32 billion by 2018. This market spans many specialties, the biggest of which is therapies for degenerative and traumatic orthopedic and spine applications. Other disorders that will benefit from cell therapies [...]
PRLog (Press Release) – Jun 09, 2010 – The practice of surgery has long employed energy-based technologies to excise, cut, ablate, cauterize, destroy or otherwise manipulate tissue to produce therapeutic results. Various energy modalities — from cryotherapy to microwave to radiofrequency to ultrasound to radiation and others — have proven their ability to effect healthy or diseased tissue [...]
Before President Barack Obama’s 2009 Executive Order that reversed the ethics-driven ban on U.S. Federal funding for human embryonic stem cell research, the European Union had a clear advantage in stem cell research. However, now that the way is clear in the United States to accelerate embryonic stem cell research there, some worry that current [...]
Western markets, including the U.S. and Europe, tend to drive the formation of new medical technology markets, which then evolve and migrate to Asia/Pacific and the rest of the world. While this is not always the case (a notable exception is the technology and market development of fibrin and other blood-based tissue sealants technologies, which [...]
Worldwide sales of cell therapy and tissue engineering products eclipsed $6.9 billion in 2009 on pace to reach $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment [...]
Contact:
